IGF2BP3 and small cell lung carcinoma: Our results indicated that IGF2BP3 mRNA expression level (p = 0.006), lymph node stage (p < 0.001), metastasis stage (p = 0.008), and tumor stage (p < 0.001) were significantly associated with the OS of patients with SCLC (Table 2).